The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

ABSTRACT: Highly pathogenic avian influenza viruses pose a continuing global threat. Current vaccines will not protect against newly evolved pandemic viruses. The creation of 'universal' vaccines has been unsuccessful because the immunological mechanisms that promote heterosubtypic immunity are incompletely defined. We found here that rapamycin, an immunosuppressive drug that inhibits the kinase mTOR, promoted cross-strain protection against lethal infection with influenza virus of various subtypes when administered during immunization with influenza virus subtype H3N2. Rapamycin reduced the formation of germinal centers and inhibited class switching in B cells, which yielded a unique repertoire of antibodies that mediated heterosubtypic protection. Our data established a requirement for the mTORC1

SUBMITTER: Keating R 

PROVIDER: S-EPMC3883080 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature